PMC4734266_01
Hematoxylin and eosin-stained tissue section exhibiting gastric cancer with hyperchromatic nuclei and scant cytoplasm (magnification, x100).
ol-11-02-1305-g00.jpg
PMC4734266_01_ol-11-02-1305-g00.jpg
f1-ol-0-0-4084
The Affiliated Jiangyin Hospital of Southeast University Medical College (Jiangyin, China). The patient underwent radical total gastrectomy, and the histopathological diagnosis was gastric adenocarcinoma (Figs. 1 and 2).
Immunohistochemistry indicated positive staining for cytokeratin 7.
ol-11-02-1305-g01.jpg
PMC4734266_01_ol-11-02-1305-g01.jpg
f2-ol-0-0-4084
The Affiliated Jiangyin Hospital of Southeast University Medical College (Jiangyin, China). The patient underwent radical total gastrectomy, and the histopathological diagnosis was gastric adenocarcinoma (Figs. 1 and 2).
(A) Anterior and (B) posterior view of whole body bone scan, indicating uptake in the left temporal bone.
ol-11-02-1305-g02.jpg
PMC4734266_01_ol-11-02-1305-g02.jpg
f3-ol-0-0-4084
Bone conduction pure tone audiometry revealed mild (35 dB) loss of sensor neural hearing on the left side. Bone scan demonstrated uptake in the left temporal bone (Figs. 3 and 4).
Bone scan of the skull revealed uptake in the left temporal bone. (A) ECT with corrected attenuation. (B) CT. (C) Fused CT and ECT images. CT, computed tomography; ECT, enhanced CT.
ol-11-02-1305-g03.jpg
PMC4734266_01_ol-11-02-1305-g03.jpg
f4-ol-0-0-4084
Bone conduction pure tone audiometry revealed mild (35 dB) loss of sensor neural hearing on the left side. Bone scan demonstrated uptake in the left temporal bone (Figs. 3 and 4).
Non-enhanced computed tomography of the temporal bone demonstrated bony destruction in the left temporal bone.
ol-11-02-1305-g04.jpg
PMC4734266_01_ol-11-02-1305-g04.jpg
f5-ol-0-0-4084
Philips Healthcare) of the brain identified an enhancing lesion in the left petrous apex (Figs. 5 and 6, respectively). Previous patients who were clinically diagnosed with metastasis to the temporal bone received radiotherapy with a total dose of 60 Gy for the treatment of the tumor mass.
Magnetic resonance imaging identified a diffuse mass in the left temporal bone. The signal corresponding to the mass lesion displayed low intensity on T2-weighted images. (A) Transversal section. (B) Median sagittal section.
ol-11-02-1305-g05.jpg
PMC4734266_01_ol-11-02-1305-g05.jpg
f6-ol-0-0-4084
Philips Healthcare) of the brain identified an enhancing lesion in the left petrous apex (Figs. 5 and 6, respectively). Previous patients who were clinically diagnosed with metastasis to the temporal bone received radiotherapy with a total dose of 60 Gy for the treatment of the tumor mass.